Platelet activation after presyncope by lower body negative pressure in humans

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Zaar, Morten ^a   Fedyk, Chriselda G ^b   Pidcoke, Heather F ^b   Scherer, Michael R ^b   Ryan, Kathy L ^b   Rickards, Caroline A ^c   Hinojosa Laborde, Carmen ^b   Convertino, Victor A ^b   Cap, Andrew P ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 8; D DIMER; DUAL SPECIFICITY PHOSPHATASE 2; FIBRINOGEN RECEPTOR; PROTEIN C; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR ANTIGEN; VON WILLEBRAND FACTOR RISTOCETIN COFACTOR; BIOLOGICAL MARKER; HORMONE; RENIN;

ADULT; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING; CONTROLLED STUDY; ERYTHROCYTE COUNT; FEMALE; FIBRINOLYSIS; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HEMOCONCENTRATION; HEMOSTASIS; HUMAN; HUMAN CELL; HYPOVOLEMIA; LOWER BODY NEGATIVE PRESSURE; MALE; PARTIAL THROMBOPLASTIN TIME; PRESYNCOPE; PROTEIN FUNCTION; PROTHROMBIN TIME; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY; VENOUS BLOOD; BLOOD; CLINICAL TRIAL; FAINTNESS;

ADULT; BIOMARKERS; BLOOD COAGULATION; FEMALE; FLOW CYTOMETRY; HORMONES; HUMANS; LOWER BODY NEGATIVE PRESSURE; MALE; PLATELET ACTIVATION; RENIN; SYNCOPE; THROMBELASTOGRAPHY;

EID: 84919934998     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116174     Document Type: Article

References (31)

1. Ruttmann TG, Roche AM, Gasson J, James MF (2003) The effects of a one unit blood donation on auto-haemodilution and coagulation. Anaesth Intensive Care 31: 40-43.
2. Zaar M, Mørkeberg J, Pott FC, Johansson PI, Secher NH (2014) Coagulation competence and fluid recruitment after moderate blood loss in young men. Blood Coagul Fibrinolysis 25: 592-596.
3. Cvirn G, Schlagenhauf A, Leschnik B, Koestenberger M, Roessler A, et al. (2012) Coagulation changes during presyncope and recovery. PLoS One 7: e42221.
4. Zaar M, Johansson PI, Nielsen LB, Crandall CG, Shibasaki M, et al. (2009) Early activation of the coagulation system during lower body negative pressure. Clin Physiol Funct Imaging 29: 427-430.
5. Masoud M, Sarig G, Brenner B, Jacob G (2008) Orthostatic hypercoagulability: a novel physiological mechanism to activate the coagulation system. Hypertension 51: 1545-1551.
6. Evans RG, Ventura S, Dampney RA, Ludbrook J (2001) Neural mechanisms in the cardiovascular responses to acute central hypovolaemia. Clin Exp Pharmacol Physiol 28: 479-487.
7. von Känel R, Dimsdale JE (2000) Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 65: 357-369.
8. Monroe DM, Hoffman M (2006) What does it take to make the perfect clot? Arterioscler Thromb Vasc Biol 26: 41-48.
9. Jennings LK (2009) Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost 102: 248-257.
10. Jacoby RC, Owings JT, Holmes J, Battistella FD, Gosselin RC, et al. (2001) Platelet activation and function after trauma. J Trauma 51: 639-647.
11. Libre EP, Cowan DH, Watkins SP Jr, Shulman NR (1968) Relationships between spleen, platelets and factor VIII levels. Blood 31: 358-368.
12. Nurden AT, Pillois X, Wilcox DA (2013) Glanzmann thrombasthenia: state of the art and future directions. Semin Thromb Hemost 39: 642-655.
13. Vlot AJ, Koppelman SJ, Bouma BN, Sixma JJ (1998) Factor VIII and von Willebrand factor. Thromb Haemost 79: 456-465.
14. Nordfang O, Kristensen HI, Valentin S, Ostergaard P, Wadt J (1993) The significance of TFPI in clotting assays-comparison and combination with other anticoagulants. Thromb Haemost 70: 448-453.
15. Park MS, Martini WZ, Dubick MA, Salinas J, Butenas S, et al. (2009) Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma 67: 266-275.
16. Bounameaux H, De Moerloose P, Perrier A, Reber G (1994) Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost 71: 1-6.
17. Ebert RV, Stead EA (1941) Demonstration that in normal man no reserves of blood are mobilized by exercise, epinephrine, and hemorrhage. Am J Med Sci 201: 655-663.
18. Schagatay E, Andersson JP, Hallen M, Palsson B (2001) Selected contribution: role of spleen emptying in prolonging apneas in humans. J Appl Physiol (1985) 90: 1623-1629.
19. Cai Y, Holm S, Jenstrup M, Strømstad M, Eigtved A, et al. (2000) Electrical admittance for filling of the heart during lower body negative pressure in humans. J Appl Physiol 89: 1569-1576.
20. Aleman MM, Walton BL, Byrnes JR, Wolberg AS (2014) Fibrinogen and red blood cells in venous thrombosis. Thromb Res 133 Suppl 1: S38-S40.
21. Austin AW, Patterson SM (2013) Comparison of stress-hemoconcentration correction techniques for stress-induced coagulation. Biomed Res Int 2013: 480648.
22. Ryan KL, Rickards CA, Hinojosa-Laborde C, Cooke WH, Convertino VA (2012) Sympathetic responses to central hypovolemia: new insights from microneurographic recordings. Front Physiol 3: 110.
23. Hjemdahl P, Linde B (1983) Influence of circulating NE and Epi on adipose tissue vascular resistance and lipolysis in humans. Am J Physiol 245: H447-H452.
24. Tomasiak M, Stelmach H, Rusak T, Ciborowski M, Radziwon P (2008) Vasopressin acts on platelets to generate procoagulant activity. Blood Coagul Fibrinolysis 19: 615-624.
25. Hariman H, Grant PJ, Hughes JR, Booth NA, Davies JA, et al. (1989) Effect of physiological concentrations of vasopressin on components of the fibrinolytic system. Thromb Haemost 61: 298-300.
26. Greenleaf JE, Petersen TW, Gabrielsen A, Pump B, Bie P, et al. (2000) Low LBNP tolerance in men is associated with attenuated activation of the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 279: R822-R829.
27. Share L (1967) Rol of peripheral receptors in the increased release of vasopressin in response to hemorrhage. Endocrinology 81: 1140-1146.
28. Hirsch AT, Majzoub JA, Ren CJ, Scales KM, Creager MA (1993) Contribution of vasopressin to blood pressure regulation during hypovolemic hypotension in humans. J Appl Physiol (1985) 75: 1984-1988.
29. Convertino VA, Sather TM (2000) Vasoactive neuroendocrine responses associated with tolerance to lower body negative pressure in humans. Clin Physiol 20: 177-184.
30. Brown NJ, Vaughan DE (1999) Role of angiotensin II in coagulation and fibrinolysis. Heart Fail Rev 3: 193-198.
31. Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, et al. (2011) The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 377: 1096-101, 1101.